Your session is about to expire
← Back to Search
Mindfulness App Training for Rumination in Adolescents
Study Summary
This trial is testing whether an app-based mindfulness course can help reduce rumination in adolescents, and whether a machine learning model can be used to identify which adolescents are predicted to benefit from the course.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have undergone mindfulness-based therapy like MBCT, DBT, or ACT.I have been on the same dose of my mental health medication for at least 2 months.I am fluent in English.I have had seizures or a head injury that made me unconscious for more than 2 minutes.You are right-handed.I have completed at least 300 minutes of mindfulness or meditation practice.I do not have any serious or unstable illnesses affecting my heart, liver, kidneys, lungs, hormones, nervous system, or blood.I do not have thoughts of harming myself.My gender and ethnicity do not limit my participation.I have a condition that could affect brain blood flow measurements.I am between 13 and 18 years old.I am between 13 and 18 years old.My gender and ethnicity do not limit my participation.You have an iPhone or Android smartphone that belongs to you.I have been on the same dose of my mental health medication for at least 2 months.I am between 13 and 18 years old.My gender and ethnicity do not limit my participation.I am fluent in English.I am fluent in English.
- Group 1: Mindfulness (Headspace app)
- Group 2: Active Control Condition
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are people of advanced age being included in this investigation?
"The eligibility criteria for this trial specify that the participants must be between 13 and 18 years old."
Are there still opportunities to participate in this investigation?
"Indeed, the information on clinicaltrials.gov verifies that this medical trial is currently enlisting patients. The research was first advertised on November 19th 2021 and updated as recently as May 11th 2022. This endeavour requires 158 individuals to be recruited from a single site."
Do I qualify for participation in this medical study?
"This investigation requires 158 participants, aged 13 to 18 years old who have been diagnosed with rumination syndrome. Furthermore, the application process necessitates that applicants: possess either an iPhone or Android phone; must be natively fluent in English; identify as any gender and ethnicity (as per inclusion of Women & Minorities policy); are right-handed individuals; can produce a CRSQ rumination subscale score if necessary; and have taken psychotropic medications for at least 2 months prior on a consistent dose."
How many participants can enroll in this medical experiment?
"Affirmative. According to clinicaltrials.gov, this investigation is currently accepting applicants; the study was initially posted on November 19th 2021 and updated most recently on May 11th 2022. A total of 158 subjects are needed from 1 medical facility."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger